Immune Response of Haemodialysis Patients Post Covid-19 Vaccination

Overview

The purpose of this study is to assess immune response of end stage renal failure patients after Covid 19 vaccination

Full Title of Study: “The Malaysian Study On Hemodialysis Patients SARS-COV-2 Vaccination Immune Response: A Prospective Observational Cohort Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: April 2022

Clinical Trial Outcome Measures

Primary Measures

  • Change From Baseline in post vaccination SARS-CoV-2 neutralizing antibody level
    • Time Frame: one year
    • Study the antibody synthesis induced by vaccination, among end stage renal failure patients, and the change in its level at 1 month, at 6 months and at 1 year after complete vaccination.

Secondary Measures

  • Change From Baseline in post vaccination SARS-CoV-2 neutralizing antibody level after 1st inoculation of the vaccine (incomplete vaccination)
    • Time Frame: one month
    • Study the antibody synthesis and the change in its level after 1st inoculation of the vaccine

Participating in This Clinical Trial

Inclusion Criteria

  • ESRF patient on hemodialysis who are eligible for the goverment Covid 19 vaccination programme – 18 years old and above – consented to join the study Exclusion Criteria:

  • patient who refused to be vaccinated – patient who deemed unsuitable for Covid vaccination

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Penang Hospital, Malaysia
  • Provider of Information About this Clinical Study
    • Principal Investigator: Dr.Ong Loke Meng, Doctor – Penang Hospital, Malaysia
  • Overall Official(s)
    • LokeMeng Ong, Principal Investigator, Penang Hospital
  • Overall Contact(s)
    • XueFang Tan, 6042225333, xf821020@hotmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.